Interleukin-32: a Pandora’s box in human immunodeficiency virus infection
Abualgasim Elgaili Abdalla, Emad Manni, Tilal Elsaman, Khalid Abosalif, Ayman Ali Mohammed Alameen, Malik Suliman Mohamed, Hasan Ejaz · 2025
Read Interleukin-32: a Pandora’s box in human immunodeficiency virus infection by Abualgasim Elgaili Abdalla, Emad Manni, Tilal Elsaman, Khalid Abosalif, Ayman Ali Mohammed Alameen, Malik Suliman Mohamed, Hasan Ejaz (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12689581.txt.
Description
Human immunodeficiency virus (HIV), which causes acquired immunodeficiency syndrome (AIDS), has been estimated to infect around 40.8 million people globally. This virus can persist and thrive in the presence of antiretroviral therapy, which is a major obstacle to HIV eradication. Therefore, understanding host immunological factors that underlie HIV persistence and pathogenesis can lead to the development of immunotherapeutic interventions.
Catalog record
| CREATOR | Abualgasim Elgaili Abdalla, Emad Manni, Tilal Elsaman, Khalid Abosalif, Ayman Ali Mohammed Alameen, Malik Suliman Mohamed, Hasan Ejaz |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |